Thank you for registering your interest in achieving a better outcome for shareholders than a takeover via Scheme of Arrangement by Qiagen at $3.55.
Before proceeding, I would like to draw to your attention the disclaimer at the end of this email.
Through this and subsequent emails it is our intention to keep you fully informed about this takeover and the actions that are available to ensure a better outcome for every Shareholder.
For obvious reasons, unfortunately, we may have to be somewhat circumspect in some of the matters that we discuss.
I am pleased to inform you that the combination of your indicated voting intentions and the votes of others who intend to vote NO ensure that we can reject this Scheme.
For this Scheme to be overturned , more than 25% of votes cast either in person or by proxy will need to vote NO. Whilst current indications are that this is very achievable we need as many votes as possible. The single most important thing that you can do at this time as an individual is to ensure that every person that you can contact registers their interest and intention.
Now, to answer some of the questions that you would no doubt already have.
Who are we?
Whilst at this point in time, I am the public face of this campaign, I can assure you that there is a very strong team of dedicated, professional long term Cellestis investors working behind the scenes on this. I do recognize that many of you would want to be more directly involved in this than you are at present. I am sure, however, that you would also recognize that our intention to approach this situation in a businesslike and professional manner dictates that we operate with a team of a manageable size.
That is not in any way to imply that your offers of help are not appreciated. In time we may contact individuals who have offered specific assistance.
In the meantime there are things that you can do. As mentioned above, we need every single Cellestis Shareholder to be aware of the Scheme that has been proposed and the impact on them. Use every tool that you have to reach out to them.
The knowledge of your moral support is also enormously appreciated.
What are our objectives?
At this early stage our objectives are best expressed as working to achieve a better outcome for Cellestis Shareholders. Whilst that statement is by necessity vague it does express our intention of retrieving for the Shareholders the true value of Cellestis.
It is clear that there are several potential outcomes and many permutations of each. It would be foolhardy to lock in any specific outcome at this point.
What we do know is that as a group we do have the power to impact the outcomes. Have no doubt that Shareholders have significant rights and the ability to exercise them. It has been done before and it can be done again.
What are we doing?
From a standing start a little more than one week ago we have made significant progress. We have assembled a team to manage this issue and we have marshalled the Shareholders into a potentially powerful force.
More specifically we have:
- Sought and received legal opinion on many aspects of the Scheme and our rights.
- Commenced the process of receiving media coverage.
- Consulted with ASIC.
- Initiated analysis of the potential outcomes.
- Commenced the planning of strategies.
And more
What Next?
Over the coming days and weeks there is much more to be done. We will clarify our specific aims. We will commence implementation of the actions foreshadowed above. We will also need to respond to new events as they occur.
Importantly, we need to ensure that everybody has access to correct and understandable facts about this situation. It is our intention to initiate the provision of same via this email list. You can help by further disseminating that information to other shareholders.
If you wish to contact the team regarding any material matters, you can reach us at cst.shareholders@gmail.com . I can guarantee that every email will be read and considered. It may not be possible to individually answer each email but any important matters will be addressed in these emails.
Vic Bula
Representative
Cellestis Shareholders Action Group
Disclaimer. Nothing in this email should be construed as personal financial or legal advice. All information is provided on the understanding that you will take whatever steps are necessary to ensure that any actions that you take are the most approriate for your own personal circumstances. The author accepts no responsibility for the impact of any consequent outcomes.
As quite a long-term, but small shareholder in Cellestis, I have been looking forward to the time when QuantiFERON products could begin to have a significant impact on TB worldwide. I wanted to be a small part of that.
ReplyDeleteThe following link presents a ‘world clock’ that tracks, among other things, morbidity and mortality from communicable diseases like TB. It can represent TB mortality dynamically, as if in real-time, along with comparisons to other causes of mortality.
http://www.poodwaddle.com/worldclock.swf
(NB. Click on 'Deaths' at left to halt the cycling and see the data on TB.)
Based on the data and statistics presented on this site, a colleague of mine calculated that reducing TB-related deaths by only 15% could have the same effect as abolishing war and declaring world peace.
It would really hurt if, when that time comes, I knew that Qiagen had bought the right to take the credit for a paltry $3.55 per share.
Franko (with thanks to AB)